EBV-Tscm Cytotoxic T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-Tscm Cytotoxic T Cells, covering 2025-03-03 to 2025-03-03. Get the full timeline:
Most recent: Clinical Trial Update: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases [Phase 1, Phase 2]